KRATEK OPIS PROJEKTA:
EVA-AISBL – edinstven vir za raziskave na področju virologije
EVA-AISBL je edina raziskovalna infrastruktura na svetu, ki se od leta 2008 v okviru koncepta „One Virology“ posveča zbiranju, karakterizaciji, proizvodnji in distribuciji referenčnih virusnih virov za podporo raziskavam na področju virologije. Medtem ko „One Health“ obravnava medsebojno povezanost med zdravjem ljudi, živali in okolja, se „One Virology“ osredotoča na proučevanje virusov kot ključnih dejavnikov v teh sistemih. Virologija je zato bistvena za reševanje izzivov v okviru »One Health«, kot so zoonoze, virusna biodiverziteta in zdravje ekosistemov.
EVA združuje edinstvene zbirke, vključno z visokorizičnimi in porajajočimi se patogeni, ter raziskovalcem iz akademskega okolja, zasebnega sektorja in javnega zdravstva omogoča etičen in pravičen dostop do visokokakovostnih virusnih virov—kot so sevi, diagnostična orodja in referenčni materiali, v popolni skladnosti z mednarodnimi predpisi. S podporo temeljnim raziskavam, inovacijam na področju razvoja cepiv, protivirusnih sredstev in diagnostike ter z globalno distribucijo referenčnih materialov EVA igra ključno vlogo pri izboljšanju pripravljenosti in odziva na izbruhe virusov.
SHORT DESCRIPTION:
EVA-AISBL a unique resource for virology research
EVA-AISBL is the only Research Infrastructure worldwide dedicated to the collection, characterisation, production, and distribution of reference viral resources to support virology research, under the “One Virology” concept, since 2008. While “One Health” addresses the interconnection between human, animal, and environmental health, “One Virology” focuses on studying viruses as key players within these systems, making virology fundamental for addressing “One Health” challenges such as zoonotic diseases, viral biodiversity, and ecosystem health.
EVA brings together unique collections, including high-risk and emerging pathogens, and provides researchers from the academic, private, and public health sectors with ethical and equitable access to high-quality viral resources—such as strains, diagnostic tools, and reference materials—in full compliance with international regulations. By supporting fundamental research, innovation in vaccine, antiviral, and diagnostic development, and by distributing reference materials globally, EVA plays a critical role in enhancing preparedness and response to viral outbreaks.
